Maternal screening and treatment for group B streptococcus.
Maternal group B streptococcus colonization can result in complications for both mother and fetus. There are two protocols for decreasing the risk of infection: antenatal cultures and intrapartum risk-factor screening. Compliance with guidelines improves with the active participation of nurses who monitor women at risk, notify clinicians when treatment is appropriate, and provide patient support and education.
James
D C
DC
Saint Louis University School of Nursing, MO, USA. jamesdc@slu.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy* / Q000635:transmission; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D017053:Infection Control / Q000379:methods / Q000592:standards; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008403:Mass Screening / Q000379:methods* / Q000451:nursing / Q000592:standards; D016389:Maternal-Child Nursing / Q000379:methods / Q000592:standards; D024802:Nurse's Role; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D011295:Prenatal Care / Q000379:methods* / Q000592:standards; D012307:Risk Factors; D012944:Social Support; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy* / Q000635:transmission; D013292:Streptococcus agalactiae; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents